top of page
®
Bismillahirrahmanirrahim
NEWS
Our Staining Protocol Has Been Published in Springer Nature!
June 5, 2025
We're thrilled to announce that our protocol, "A Simplified and Robust Immunofluorescence Labeling Method for Complex 3D Cell Cultures: Minimizing Manipulation and Maximizing Data in Whole-Mount Analysis of Organoids, Spheroids, and Co-culture Models," has been officially published!
​
The protocol aims to simplify and enhance 3D cell culture analysis as a valuable resource for researchers working with organoids, spheroids, and co-culture models.
​
https://doi.org/10.1007/7651_2025_634
Cellorama
Revolutionizing 3D cell analysis during preclinical studies with its innovative patent-pending technologies. Providing a streamlined, all-in-one solutions that enables 3D cell analysis, improving results and minimizing waste.
Cellorama
is an M2D2 $200K Challenge Finalist!
March 10, 2025
Cellorama has been selected among the 15 finalists who will pitch at this year's $200K Challenge between nearly 200 applications worldwide!
The Organoid Video, a testament to our cutting-edge technology, has proudly secured the Grand Prize!
​
February 25, 2025
Ranan Aktas has been honored with the Grand Prize in The Terasaki Institute for Biomedical Innovation's prestigious "Beyond the Horizon: The Future of Bioengineering" media contest.
A groundbreaking new study including Cellorama's technologies published in Scientific Reports:
The use of hyaluronic acid in a 3D biomimetic scaffold supports spheroid formation and the culture of cancer stem cells (Demirel et al. 2024)
https://www.nature.com/articles/s41598-024-69047-6
ISSN 2831-8331
Cellorama's commitment
to innovation and excellence
has been recognized with the 2024 Top Cell Culture Solutions Provider Award by
Life Sciences Review.
Cellorama was selected
to participate in the
2023 MassChallenge
Early Stage Accelerator
in the Foundation Cohort.
Cellorama has been selected to receive funding from the MERT 2.0 EDA Prototype Awards Program. University of Massachusetts Lowell will support the development of the prototype of CellO™-S, a uniquely designed cell culture container for boosting spheroid formation, for drug design and drug screening experiments.
March 2023
Novel 3D Cell Culture Technologies
Our recent publication provides an overview of entire technology intended to improve organoid and spheroid studies:
Culturing, Freezing, Processing, and Imaging of Entire Organoids and Spheroids While Still in a Hydrogel.
J. Vis. Exp. (190), e64563, doi:10.3791/64563 (2022).
Cellorama received a MERT 2.0 grant, funded through the US Economic Development Administration, which aims to support innovation and strengthen supply chains in Massachusetts. Cellorama is partnering with the Empire Group, a full-service product development and manufacturing company located in Attleboro, MA.
July 2022
Cellorama participated in the Scale Up! Rhode Island Accelerator program in 2022, sponsored by 401 Tech Bridge and Polaris MEP, teaming up with expert consultants to help regional companies move toward commercialization and scalable production.
Cellorama was one of 25 companies selected for the pitch competition at Massachusetts Life Science Innovation Day in Boston in July 2022.
Cellorama was one of 100 start-up companies worldwide invited to the Advanced Therapies Expo in London in May 2022.
bottom of page